Blogs

The advent of General Artificial Intelligence (Gen AI) promises a seismic shift in the pharmaceutical industry. With its capability to automate tasks, enhance decision-making, and improve customer experiences, Gen AI stands at the forefront of a technological revolution.

When it comes to health economic modeling, the way we estimate patient survival is crucial for determining the cost-effectiveness of healthcare interventions. Traditionally, this has been done using general population mortality statistics to predict future survival rates. But is this approach still valid in a world where healthcare is rapidly advancing?